Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L1PQ
|
|||
Former ID |
DNC004988
|
|||
Drug Name |
3-(3-Pyridin-2-yl-pyrrol-1-yl)-benzonitrile
|
|||
Synonyms |
CHEMBL361325; 3-(3-Pyridin-2-yl-pyrrol-1-yl)-benzonitrile; SCHEMBL5100840; VWIHRRSEESXDSS-UHFFFAOYSA-N; ZINC13582313; BDBM50151897
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H11N3
|
|||
Canonical SMILES |
C1=CC=NC(=C1)C2=CN(C=C2)C3=CC=CC(=C3)C#N
|
|||
InChI |
1S/C16H11N3/c17-11-13-4-3-5-15(10-13)19-9-7-14(12-19)16-6-1-2-8-18-16/h1-10,12H
|
|||
InChIKey |
VWIHRRSEESXDSS-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity. J Med Chem. 2004 Sep 9;47(19):4645-8. Letter |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.